StockData
Bausch Health Companies Inc. logo

Bausch Health Companies Inc. (BHC) stock

BHCNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3077% below fair value
$8.47+0.05 (+0.59%)

Close on Nov 17, 2026Market cap $3.17BP/E –Yield –

Bausch Health Companies total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Bausch Health Companies's total debt was $20.64B at Sep 30, 2026. For fiscal 2025 it was $20.82B, down 3.7% from the year before. Over ten years it grew -3.9% a year on average. The highest annual figure on record is $31.10B in fiscal 2015.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$20.82B-3.7%
FY2024Dec 31, 2024$21.62B-3.4%
FY2023Dec 31, 2023$22.39B+7.8%
FY2022Dec 31, 2022$20.77B-8.3%
FY2021Dec 31, 2021$22.65B-5.3%
FY2020Dec 31, 2020$23.93B-7.6%
FY2019Dec 31, 2019$25.90B+6.5%
FY2018Dec 31, 2018$24.31B-4.5%
FY2017Dec 31, 2017$25.44B-14.8%
FY2016Dec 31, 2016$29.85B-4.0%
FY2015Dec 31, 2015$31.10B+104.2%
FY2014Dec 31, 2014$15.24B-12.3%
FY2013Dec 31, 2013$17.38B+57.6%
FY2012Dec 31, 2012$11.03B+65.8%
FY2011Dec 31, 2011$6.65B+85.0%
FY2010Dec 31, 2010$3.60B+1002.6%
FY2009Dec 31, 2009$326.09M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$20.64B-1.9%
Q2 FY2026Jun 30, 2026$20.74B-4.6%
Q1 FY2026Mar 31, 2026$20.76B-3.5%
Q4 FY2025Dec 31, 2025$20.82B-3.7%
Q3 FY2025Sep 30, 2025$21.04B-2.2%
Q2 FY2025Jun 30, 2025$21.74B+0.4%
Q1 FY2025Mar 31, 2025$21.51B-2.6%
Q4 FY2024Dec 31, 2024$21.62B-3.4%
Q3 FY2024Sep 30, 2024$21.51B-4.1%
Q2 FY2024Jun 30, 2024$21.66B+5.4%
Q1 FY2024Mar 31, 2024$22.07B+6.9%
Q4 FY2023Dec 31, 2023$22.39B+7.8%
Q3 FY2023Sep 30, 2023$22.43B+5.7%
Q2 FY2023Jun 30, 2023$20.55B-5.8%
Q1 FY2023Mar 31, 2023$20.65B-10.9%
Q4 FY2022Dec 31, 2022$20.77B-8.3%
Q3 FY2022Sep 30, 2022$21.22B-5.1%
Q2 FY2022Jun 30, 2022$21.81B-6.9%
Q1 FY2022Mar 31, 2022$23.17B-2.4%
Q4 FY2021Dec 31, 2021$22.65B-5.3%
Q3 FY2021Sep 30, 2021$22.36B-8.2%
Q2 FY2021Jun 30, 2021$23.44B-3.8%
Q1 FY2021Mar 31, 2021$23.74B-2.8%
Q4 FY2020Dec 31, 2020$23.93B-7.6%
Q3 FY2020Sep 30, 2020$24.34B+3.3%
Q2 FY2020Jun 30, 2020$24.36B+1.2%
Q1 FY2020Mar 31, 2020$24.43B+1.0%
Q4 FY2019Dec 31, 2019$25.90B+6.5%
Q3 FY2019Sep 30, 2019$23.57B-4.7%
Q2 FY2019Jun 30, 2019$24.08B-4.0%
Q1 FY2019Mar 31, 2019$24.18B-4.3%
Q4 FY2018Dec 31, 2018$24.31B-4.5%
Q3 FY2018Sep 30, 2018$24.73B-8.9%
Q2 FY2018Jun 30, 2018$25.09B-11.9%
Q1 FY2018Mar 31, 2018$25.27B-11.5%
Q4 FY2017Dec 31, 2017$25.44B-14.8%
Q3 FY2017Sep 30, 2017$27.14B–
Q2 FY2017Jun 30, 2017$28.46B–
Q1 FY2017Mar 31, 2017$28.55B–
Q4 FY2016Dec 31, 2016$29.85B–

More Bausch Health Companies figures

See a number that looks wrong?